Back to search

The Prevalence and Prognostic Value of BRAF Mutation in Thyroid Cancer

Data up to Jan 2025

Published2007
Citations463
References24

Total Citations Per Year

Abstract

References (24)

Increasing Incidence of Thyroid Cancer in the United States, 1973-2002

2006 • 3,243 citations

BRAF mutation in thyroid cancer

2005 • 1,260 citations

Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival

2004 • 1,155 citations

BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary Carcinomas

2003 • 1,042 citations

BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid Cancer

2005 • 956 citations

An Observation Trial Without Surgical Treatment in Patients with Papillary Microcarcinoma of the Thyroid

2003 • 840 citations

Clinical Implication of Hot SpotBRAFMutation, V599E, in Papillary Thyroid Cancers

2003 • 539 citations

High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.

2003 • 424 citations

Targeted Expression of BRAFV600E in Thyroid Cells of Transgenic Mice Results in Papillary Thyroid Cancers that Undergo Dedifferentiation

2005 • 415 citations

BRAFV599EMutation Is the Leading Genetic Event in Adult Sporadic Papillary Thyroid Carcinomas

2004 • 268 citations

Independent Clonal Origins of Distinct Tumor Foci in Multifocal Papillary Thyroid Carcinoma

2005 • 243 citations

The BRAF mutation is useful for prediction of clinical recurrence in low‐risk patients with conventional papillary thyroid carcinoma

2006 • 243 citations

Correlation between B-RAFV600E mutation and clinico–pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature

2006 • 237 citations

The BRAFV600E mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma

2005 • 216 citations

Differentiated Thyroid Cancer: “Complete” Rational Approach

2000 • 188 citations

BRAF mutations in an Italian cohort of thyroid cancers

2004 • 180 citations

BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment

2004 • 176 citations

Influence of the BRAF V600E Mutation on Expression of Vascular Endothelial Growth Factor in Papillary Thyroid Cancer

2006 • 158 citations

Conditional Activation of RET/PTC3 and BRAFV600E in Thyroid Cells Is Associated with Gene Expression Profiles that Predict a Preferential Role of BRAF in Extracellular Matrix Remodeling

2006 • 135 citations

No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan

2005 • 124 citations

Analysis of differential BRAFV600E mutational status in multifocal papillary thyroid carcinoma

2006 • 123 citations

Lymphatic Mapping Establishes the Role of BRAF Gene Mutation in Papillary Thyroid Carcinoma

2006 • 84 citations

B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas

2006 • 82 citations

The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma

2004 • 79 citations

Cited By (0)

No citing papers found in database

The Prevalence and Prognostic Value of BRAF Mutation in Thyroid Cancer (2007) – Annals of Surgery | Metascience Observatory Explorer